Poly(ethylene carbonate) as a surface-eroding biomaterial for in situ forming parenteral drug delivery systems: A feasibility study

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 76, Issue 2, 2010, Pages 222-229

  Liu, Yu ^a   Kemmer, Annette ^a   Keim, Klaus ^a   Curdy, Catherine ^b   Petersen, Holger ^b   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Morphology of depots; Poly(ethylene carbonate); Rheological properties; Solubility; Solvent release rate

Indexed keywords

BIOMATERIAL; BOVINE SERUM ALBUMIN; ORGANIC SOLVENT; POLY(ETHYLENE CARBONATE); POLYMER; UNCLASSIFIED DRUG;

ARTICLE; DEVICE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FLOW KINETICS; MORPHOLOGY; PHYSICAL PARAMETERS; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; TRANSITION TEMPERATURE;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CATTLE; DELAYED-ACTION PREPARATIONS; DIMETHYL SULFOXIDE; DRUG DELIVERY SYSTEMS; DRUG STORAGE; FEASIBILITY STUDIES; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; POLYETHYLENES; PYRROLIDINONES; SERUM ALBUMIN, BOVINE; SOLUBILITY; SOLVENTS; TEMPERATURE; TIME FACTORS; VISCOSITY;

EID: 77957281434     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.07.009     Document Type: Article

References (51)

1. Hatefi A., Amsden B. Biodegradable injectable in situ forming drug delivery system. J. Control. Release 2002, 80:9-28.
2. Packhaeuser C.B., Schnieders J., Oster C.G., Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur. J. Pharm. Biopharm. 2004, 58:445-455.
3. Davis S.S., Illum L. Colloidal drug delivery systems: opportunities and challenges. Site-Specific Drug Delivery 1986, 210-224. Wiley, New York. E. Tomlinson, S.S. Davis (Eds.).
4. Collins-Gold L.C., Lyons R.T., Batholow L.C. Parenteral emulsion for drug delivery. Adv. Drug Deliv. Rev. 1990, 5:189-208.
5. Florence A.T., Whitehill D. The formulation and stability of multiple emulsions. Int. J. Pharm. 1982, 11:277-308.
6. Sharma A., Sharma U.S. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 1997, 154:123-140.
7. Moghimi S.M. Opsono-recognition of liposomes by tissue macrophages. Int. J. Pharm. 1998, 162:11-18.
8. Zhang X., Jackson J.K., Bert H.M. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int. J. Pharm. 1996, 132:195-206.
9. Chen L., Apte R.N., Cohen S. Characterization of PLGA microspheres for the controlled delivery of IL-I for tumor immunotherapy. J. Control. Release 1997, 43:261-272.
10. Espuelas M.S., Legrand P., Irache J.M., Gamazo C., Orecchinioni A.M., Devissaguet J.Ph., Ygartua P. Poly(caprolactone) nanospheres as an alternative way to reduce amphotericin B toxicity. Int. J. Pharm. 1997, 158:19-27.
11. R.L. Dunn, J.P. English, D.R. Cowsar, D.P. Vanderbilt, Biodegradable in-situ forming implants and methods of producing the same, US Patent 4938,763, 1990.
12. R.L. Dunn, A.J. Tipton, G.L. Southard, Biodegradable polymer compositions for implants, Eur. Pat. Appl. 539751 A1 19930505, 1993.
13. R.L Dunn, N.L. Krinick, M.S. Cox, K.R. Josephs, Liquid polymer delivery system comprising biodegradable, water-insoluble polymer, PCT Int. Appl. WO 9621427 A1 19960718, 1996.
14. Lambert W.J., Peck K.D. Development of an in situ forming biodegradable poly-lactide-co-glycolide system for the controlled release of proteins. J. Control. Release 1995, 33:189-195.
15. Shively M.L., Coonts B.A., Renner W.D., Southard J.L., Bennett A.T. Physico-chemical characterization of a polymeric injectable implant delivery system. J. Control. Release 1995, 33:237-243.
16. Wang L., Venkatraman S., Kleiner L. Drug release from injectable depots: two different in vitro mechanisms. J. Control. Release 2004, 99:207-216.
17. Dong W.Y., Koerber M., Esguera V.L., Bodmeier R. Stability of poly (d,l-lactide-co-glyolide) and leuprolide acetate in-situ forming drug delivery systems. J. Control. Release 2006, 115:158-167.
18. Haglung B.O., Rajashree J., Himmelstein K.J. An in-situ gelling system for parenteral delivery. J. Control. Release 1996, 41:229-235.
19. Ismail F.A., Napaporn J., Hughes J.A., Brazeau G.A. In situ gel formation for gene delivery: release and myotoxicity studies. Pharm. Dev. Technol. 2000, 5:391-397.
20. Körber M., Bodmeier R. Development of in situ forming PLGA drug delivery system, I: characterization of a non-aqueous protein precipitation. Eur. J. Pharm. Sci. 2008, 35:283-292.
21. Acemoglu M., Nimmerfall F., Bantle S., Stoll G.H. Poly(ethylene carbonate)s, part I: syntheses and structural effects on biodegradation. J. Control. Release 1997, 49:263-276.
22. Stoll G.H., Nimmerfall F., Acemoglu M., Bodmer D., Bantle S., Mueller I., Mahl A., Kolopp M., Tullberg K. Poly(ethylene carbonate)s, part II: degradation mechanism and parenteral delivery of bioactive agents. J. Control. Release 2001, 76:209-225.
23. Dadsetan M., Christenson E.M., Unger F., Ausborn M., Kissel T., Hiltner A., Anderson J.M. In vivo biocompatibility and biodegradation of poly(ethylene carbonate). J. Control. Release 2003, 93:259-270.
24. Acemoglu M. Chemistry of polymer biodegradation and implications on parenteral drug delivery. Int. J. Pharm. 2004, 277:133-139.
25. Lambert O., Nagele O., Loux V., Bonny J.-D., Marchal-Heussler L. Poly(ethylene carbonate) microspheres: manufacturing process and internal structure characterization. J. Control. Release 2000, 67:89-99.
26. Thumm W., Freitay D., Kettrup A. Determination and quantification of dimethyl sulphoxide hy HPLC. Chromatographia 1991, 32:461-462.
27. Shea J.A., Cook S.C., Shamrock W.F., Segretario J. Quantitation of residual N-methylpyrrolidone in losoxantrone hydrochloride by reversed-phase high-performance liquid chromatography. J. Chromatogr.Sci. 1998, 36:187-190.
28. Kranz H., Bodmeier R. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles. Eur. J. Pharm. Sci. 2008, 34:164-172.
29. Barton A.F.M. Solubility parameters. Chem. Rev. 1975, 75:731-753.
30. Kranz H., Brazeau G.A., Napaporn J., Martin R.L., Millard W., Bodmeier R. Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems. Int. J. Pharm. 2001, 212:11-18.
31. Houen G. The solubility of protein in organic solvents. Acta Chem. Scand. 1996, 50:68-70.
32. Park T.G., Lee H.Y., Nam Y.S. A new preparation method for protein loaded poly(d,l-lactic-co-glycolic acid) microspheres and protein release mechanism study. J. Control. Release 1998, 55:181-191.
33. Stevenson C.L., Leonard J.L., Hall S.C. Effect of peptide concentration and temperature on leuprolide stability in dimethyl sulfoxide. Int. J. Pharm. 1999, 191:115-129.
34. Strickley R.G. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 2004, 21:201-230.
35. Bristow G.M., Watson W.F. Cohesive energy densities of polymers. Part I: cohesive energy densities of rubbers by swelling measurement. Trans. Faraday Soc. 1958, 54:1731-1741.
36. Yilmaz L., McHugh A.J. Analysis of nonsolvent-solvent-polymer phase diagrams and their relevance to membrane formation modelling. J. Appl. Polym. Sci. 1986, 31:997-1018.
37. Graham P.D., Brodbeck K.J., McHugh A.J. Phase inversion dynamic of PLGA solutions related to drug delivery. J. Control. Release 1999, 58:233-245.
38. Barton B.F., Reeve J.L., McHugh A.J. Observation on the dynamic of nonsolvent-induced phase inversion. J. Polym. Sci. Polym. Phys. Ed. 1997, 35:569-585.
39. Yang S., Liu Z.Z. Preparation and characterization of polyacrylnitrile ultrafiltration membranes. J. Membr. Sci. 2003, 222:87-98.
40. Kim J.H., Lee K.H. Effect of PEG additive on membrane formation by phase inversion. J. Membr. Sci. 1998, 138:153-163.
41. Zhang Q.Z., Wang P., Yang Y.N. Rheological and thermodynamic variation in polysulfone solution by PEG introduction and its effect on kinetics of membrane formation via phase-inversion process. J. Membr. Sci. 2006, 279:230-237.
42. Wang L., Kleiner L., Venkatraman S. Structure formation in injectable poly(lactide-co-glycolide) depots. J. Control. Release 2003, 90:345-354.
43. DesNoyer J.R., McHugh A.J. The effect of pluronic on the protein release kinetics of an injectable drug delivery system. J. Control. Release 2003, 86:15-24.
44. Wang L., Venkatraman S., Gan L.H., Kleiner L. Structure formation in injectable poly(lactide-co-glycolide) depots II: nature of gel. J. Biomed. Mater. Res. B Appl. Biomater. 2005, 72:215-222.
45. Larson R.G. The Structure and Rheology of Complex Fluids 1999, Oxford University Press, New York.
46. Huang W.H., Matsuoka S., Kwei T.K., Okamoto Y. Aggregation and gelation of fully conjugated rigid-rod polymers: poly(2,5-dialkyl-1,4-phenylenethylene)s. Macromolecules 2001, 34:7166-7171.
47. Saiani A., Spevacek J., Guenet J.M. Phase behavior and polymer/solvent interactions in thermoreversible gels of syndiotactic poly(methyl methacrylate). Macromolecules 1998, 31:703-710.
48. Jeong B., Bae Y.H., Kim S.W. Thermoreversible gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions. Macromolecules 1999, 32:7064-7069.
49. Brodbeck K.J., DesNoyer J.R., McHugh A.J. Phase inversion dynamic of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. J. Control. Release 1999, 62:333-344.
50. McHugh A.J., Miller D.C. The dynamics of diffusion and gel growth during nonsolvent-induced phase inversion of polyethersulfone. J. Membr. Sci. 1995, 105:121-136.
51. Boom R.M., Wienk I.M., Van den Boomgaard Th., Smolders C.A. Microstructures in phase inversion membranes. Part 2. The role of a polymeric additives. J. Membr. Sci. 1992, 73:277-292.